Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway

Hepatocellular carcinoma (HCC) is a deadly malignancy with limited treatment options. Activation of the AKT/mTOR cascade is one of the most frequent events along hepatocarcinogenesis. mTOR is a serine/threonine kinase and presents in two distinct complexes: mTORC1 and mTORC2. While mTORC1 has been e...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Exp Mol Med
Päätekijät: Xu, Zhong, Hu, Junjie, Cao, Hui, Pilo, Maria G, Cigliano, Antonio, Shao, Zixuan, Xu, Meng, Ribback, Silvia, Dombrowski, Frank, Calvisi, Diego F, Chen, Xin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2018
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992985/
https://ncbi.nlm.nih.gov/pubmed/29303510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emm.2017.158
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia